PMC:3586680 / 836-1052 JSONTXT

Annnotations TAB JSON ListView MergeView

    test3

    {"project":"test3","denotations":[{"id":"T78","span":{"begin":152,"end":155},"obj":"Protein"},{"id":"T77","span":{"begin":109,"end":113},"obj":"Protein"},{"id":"T76","span":{"begin":76,"end":80},"obj":"Protein"},{"id":"T75","span":{"begin":23,"end":26},"obj":"Protein"},{"id":"T58","span":{"begin":152,"end":155},"obj":"Protein"},{"id":"T57","span":{"begin":109,"end":113},"obj":"Protein"},{"id":"T56","span":{"begin":76,"end":80},"obj":"Protein"},{"id":"T55","span":{"begin":23,"end":26},"obj":"Protein"}],"text":"t wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to overcome TMZ resistance a"}

    testone

    {"project":"testone","denotations":[{"id":"T36","span":{"begin":152,"end":155},"obj":"Protein"},{"id":"T35","span":{"begin":109,"end":113},"obj":"Protein"},{"id":"T34","span":{"begin":76,"end":80},"obj":"Protein"},{"id":"T33","span":{"begin":23,"end":26},"obj":"Protein"}],"text":"t wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to overcome TMZ resistance a"}

    bionlp-st-ge-2016-test-tees

    {"project":"bionlp-st-ge-2016-test-tees","denotations":[{"id":"T496","span":{"begin":167,"end":177},"obj":"Negative_regulation"},{"id":"T495","span":{"begin":152,"end":155},"obj":"Protein"},{"id":"T494","span":{"begin":41,"end":49},"obj":"Regulation"},{"id":"T493","span":{"begin":76,"end":80},"obj":"Protein"},{"id":"T492","span":{"begin":23,"end":26},"obj":"Protein"}],"relations":[{"id":"R246","pred":"causeOf","subj":"T492","obj":"T494"},{"id":"R247","pred":"themeOf","subj":"T493","obj":"T494"},{"id":"R248","pred":"themeOf","subj":"T495","obj":"T496"}],"text":"t wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to overcome TMZ resistance a"}

    bionlp-st-ge-2016-spacy-parsed

    {"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T723","span":{"begin":204,"end":214},"obj":"NN"},{"id":"T722","span":{"begin":200,"end":203},"obj":"NNP"},{"id":"T721","span":{"begin":191,"end":199},"obj":"VB"},{"id":"T720","span":{"begin":188,"end":190},"obj":"TO"},{"id":"T719","span":{"begin":181,"end":187},"obj":"VBN"},{"id":"T718","span":{"begin":178,"end":180},"obj":"VBZ"},{"id":"T717","span":{"begin":167,"end":177},"obj":"NN"},{"id":"T716","span":{"begin":156,"end":166},"obj":"JJ"},{"id":"T715","span":{"begin":152,"end":155},"obj":"NN"},{"id":"T713","span":{"begin":140,"end":145},"obj":"NNS"},{"id":"T712","span":{"begin":128,"end":139},"obj":"JJ"},{"id":"T711","span":{"begin":125,"end":127},"obj":"IN"},{"id":"T710","span":{"begin":114,"end":124},"obj":"NN"},{"id":"T709","span":{"begin":109,"end":113},"obj":"NNP"},{"id":"T708","span":{"begin":98,"end":108},"obj":"VBG"},{"id":"T707","span":{"begin":93,"end":97},"obj":"IN"},{"id":"T706","span":{"begin":85,"end":92},"obj":"VBP"},{"id":"T705","span":{"begin":82,"end":84},"obj":"PRP"},{"id":"T704","span":{"begin":80,"end":81},"obj":"."},{"id":"T703","span":{"begin":76,"end":80},"obj":"NNP"},{"id":"T702","span":{"begin":73,"end":75},"obj":"IN"},{"id":"T701","span":{"begin":64,"end":72},"obj":"NN"},{"id":"T700","span":{"begin":54,"end":63},"obj":"JJ"},{"id":"T699","span":{"begin":50,"end":53},"obj":"DT"},{"id":"T698","span":{"begin":41,"end":49},"obj":"VBP"},{"id":"T697","span":{"begin":39,"end":40},"obj":","},{"id":"T696","span":{"begin":31,"end":39},"obj":"NNS"},{"id":"T695","span":{"begin":28,"end":30},"obj":"CC"},{"id":"T694","span":{"begin":26,"end":27},"obj":","},{"id":"T693","span":{"begin":23,"end":26},"obj":"NN"},{"id":"T692","span":{"begin":16,"end":22},"obj":"JJ"},{"id":"T691","span":{"begin":12,"end":15},"obj":"CC"},{"id":"T690","span":{"begin":7,"end":11},"obj":"NN"},{"id":"T689","span":{"begin":2,"end":6},"obj":"JJ"},{"id":"T714","span":{"begin":146,"end":151},"obj":"IN"}],"relations":[{"id":"R401","pred":"amod","subj":"T689","obj":"T690"},{"id":"R402","pred":"nsubj","subj":"T690","obj":"T698"},{"id":"R403","pred":"cc","subj":"T691","obj":"T690"},{"id":"R404","pred":"amod","subj":"T692","obj":"T693"},{"id":"R405","pred":"conj","subj":"T693","obj":"T690"},{"id":"R406","pred":"punct","subj":"T694","obj":"T693"},{"id":"R407","pred":"cc","subj":"T695","obj":"T693"},{"id":"R408","pred":"conj","subj":"T696","obj":"T693"},{"id":"R409","pred":"punct","subj":"T697","obj":"T698"},{"id":"R411","pred":"det","subj":"T699","obj":"T701"},{"id":"R412","pred":"amod","subj":"T700","obj":"T701"},{"id":"R413","pred":"dobj","subj":"T701","obj":"T698"},{"id":"R414","pred":"prep","subj":"T702","obj":"T701"},{"id":"R415","pred":"pobj","subj":"T703","obj":"T702"},{"id":"R417","pred":"nsubj","subj":"T705","obj":"T706"},{"id":"R418","pred":"ROOT","subj":"T706","obj":"T706"},{"id":"R419","pred":"mark","subj":"T707","obj":"T719"},{"id":"R420","pred":"csubj","subj":"T708","obj":"T719"},{"id":"R421","pred":"compound","subj":"T709","obj":"T710"},{"id":"R422","pred":"dobj","subj":"T710","obj":"T708"},{"id":"R423","pred":"prep","subj":"T711","obj":"T710"},{"id":"R424","pred":"amod","subj":"T712","obj":"T713"},{"id":"R425","pred":"pobj","subj":"T713","obj":"T711"},{"id":"R426","pred":"amod","subj":"T715","obj":"T717"},{"id":"R427","pred":"amod","subj":"T716","obj":"T717"},{"id":"R428","pred":"pobj","subj":"T717","obj":"T714"},{"id":"R429","pred":"auxpass","subj":"T718","obj":"T719"},{"id":"R430","pred":"ccomp","subj":"T719","obj":"T706"},{"id":"R431","pred":"aux","subj":"T720","obj":"T721"},{"id":"R432","pred":"advcl","subj":"T721","obj":"T719"},{"id":"R433","pred":"compound","subj":"T722","obj":"T723"},{"id":"R434","pred":"dobj","subj":"T723","obj":"T721"},{"id":"R443","pred":"prep","subj":"T714","obj":"T710"}],"text":"t wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to overcome TMZ resistance a"}

    bionlp-st-ge-2016-test-ihmc

    {"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T548","span":{"begin":109,"end":124},"obj":"Positive_regulation"},{"id":"T545","span":{"begin":109,"end":113},"obj":"Protein"},{"id":"T544","span":{"begin":200,"end":203},"obj":"Entity"},{"id":"T542","span":{"begin":128,"end":145},"obj":"Entity"},{"id":"T536","span":{"begin":152,"end":155},"obj":"Protein"},{"id":"T530","span":{"begin":73,"end":80},"obj":"Protein"},{"id":"T528","span":{"begin":16,"end":40},"obj":"Protein"}],"relations":[{"id":"R264","pred":"themeOf","subj":"T545","obj":"T548"}],"text":"t wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to overcome TMZ resistance a"}

    DLUT931

    {"project":"DLUT931","denotations":[{"id":"T424","span":{"begin":98,"end":108},"obj":"Positive_regulation"},{"id":"T423","span":{"begin":167,"end":177},"obj":"Negative_regulation"},{"id":"T422","span":{"begin":114,"end":124},"obj":"Positive_regulation"},{"id":"T421","span":{"begin":41,"end":49},"obj":"Regulation"},{"id":"T414","span":{"begin":152,"end":155},"obj":"Protein"},{"id":"T413","span":{"begin":109,"end":113},"obj":"Protein"},{"id":"T412","span":{"begin":76,"end":80},"obj":"Protein"},{"id":"T411","span":{"begin":23,"end":26},"obj":"Protein"}],"relations":[{"id":"R218","pred":"causeOf","subj":"T411","obj":"T421"},{"id":"R219","pred":"themeOf","subj":"T412","obj":"T421"},{"id":"R220","pred":"themeOf","subj":"T413","obj":"T422"},{"id":"R221","pred":"themeOf","subj":"T414","obj":"T423"},{"id":"R224","pred":"themeOf","subj":"T422","obj":"T424"},{"id":"R225","pred":"causeOf","subj":"T423","obj":"T424"}],"text":"t wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to overcome TMZ resistance a"}

    BioNLP16_Messiy

    {"project":"BioNLP16_Messiy","denotations":[{"id":"T473","span":{"begin":114,"end":124},"obj":"Positive_regulation"},{"id":"T472","span":{"begin":98,"end":108},"obj":"Positive_regulation"},{"id":"T471","span":{"begin":167,"end":177},"obj":"Negative_regulation"},{"id":"T464","span":{"begin":152,"end":155},"obj":"Protein"},{"id":"T463","span":{"begin":109,"end":113},"obj":"Protein"},{"id":"T462","span":{"begin":76,"end":80},"obj":"Protein"},{"id":"T461","span":{"begin":23,"end":26},"obj":"Protein"}],"relations":[{"id":"R234","pred":"themeOf","subj":"T463","obj":"T473"},{"id":"R235","pred":"themeOf","subj":"T464","obj":"T471"},{"id":"R238","pred":"themeOf","subj":"T473","obj":"T472"}],"text":"t wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to overcome TMZ resistance a"}

    BioNLP16_DUT

    {"project":"BioNLP16_DUT","denotations":[{"id":"T380","span":{"begin":98,"end":108},"obj":"Positive_regulation"},{"id":"T379","span":{"begin":114,"end":124},"obj":"Positive_regulation"},{"id":"T378","span":{"begin":167,"end":177},"obj":"Negative_regulation"},{"id":"T372","span":{"begin":152,"end":155},"obj":"Protein"},{"id":"T371","span":{"begin":109,"end":113},"obj":"Protein"},{"id":"T370","span":{"begin":76,"end":80},"obj":"Protein"},{"id":"T369","span":{"begin":23,"end":26},"obj":"Protein"}],"relations":[{"id":"R208","pred":"themeOf","subj":"T371","obj":"T379"},{"id":"R209","pred":"themeOf","subj":"T372","obj":"T378"},{"id":"R211","pred":"themeOf","subj":"T379","obj":"T380"}],"text":"t wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to overcome TMZ resistance a"}

    bionlp-st-ge-2016-uniprot

    {"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T395","span":{"begin":23,"end":26},"obj":"http://www.uniprot.org/uniprot/P04637"},{"id":"T387","span":{"begin":76,"end":80},"obj":"http://www.uniprot.org/uniprot/Q9NZC7"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"t wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to overcome TMZ resistance a"}

    bionlp-st-ge-2016-test-proteins

    {"project":"bionlp-st-ge-2016-test-proteins","denotations":[{"id":"T132","span":{"begin":23,"end":26},"obj":"Protein"},{"id":"T133","span":{"begin":76,"end":80},"obj":"Protein"},{"id":"T134","span":{"begin":109,"end":113},"obj":"Protein"},{"id":"T135","span":{"begin":152,"end":155},"obj":"Protein"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"t wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to overcome TMZ resistance a"}

    pmc-enju-pas

    {"project":"pmc-enju-pas","denotations":[{"id":"T331","span":{"begin":204,"end":214},"obj":"NN"},{"id":"T330","span":{"begin":200,"end":203},"obj":"NN"},{"id":"T329","span":{"begin":191,"end":199},"obj":"VB"},{"id":"T328","span":{"begin":188,"end":190},"obj":"TO"},{"id":"T327","span":{"begin":181,"end":187},"obj":"VB"},{"id":"T326","span":{"begin":178,"end":180},"obj":"VB"},{"id":"T325","span":{"begin":167,"end":177},"obj":"NN"},{"id":"T324","span":{"begin":156,"end":166},"obj":"JJ"},{"id":"T323","span":{"begin":152,"end":155},"obj":"NN"},{"id":"T322","span":{"begin":146,"end":151},"obj":"IN"},{"id":"T321","span":{"begin":140,"end":145},"obj":"NN"},{"id":"T320","span":{"begin":128,"end":139},"obj":"JJ"},{"id":"T319","span":{"begin":125,"end":127},"obj":"IN"},{"id":"T318","span":{"begin":114,"end":124},"obj":"NN"},{"id":"T317","span":{"begin":109,"end":113},"obj":"NN"},{"id":"T316","span":{"begin":98,"end":108},"obj":"VB"},{"id":"T315","span":{"begin":93,"end":97},"obj":"IN"},{"id":"T314","span":{"begin":85,"end":92},"obj":"VB"},{"id":"T313","span":{"begin":82,"end":84},"obj":"PRP"},{"id":"T312","span":{"begin":76,"end":80},"obj":"NN"},{"id":"T311","span":{"begin":73,"end":75},"obj":"IN"},{"id":"T310","span":{"begin":64,"end":72},"obj":"NN"},{"id":"T309","span":{"begin":54,"end":63},"obj":"JJ"},{"id":"T308","span":{"begin":50,"end":53},"obj":"DT"},{"id":"T307","span":{"begin":41,"end":49},"obj":"VB"},{"id":"T306","span":{"begin":39,"end":40},"obj":"-COMMA-"},{"id":"T305","span":{"begin":31,"end":39},"obj":"NN"},{"id":"T304","span":{"begin":28,"end":30},"obj":"CC"},{"id":"T303","span":{"begin":26,"end":27},"obj":"-COMMA-"},{"id":"T302","span":{"begin":23,"end":26},"obj":"NN"},{"id":"T301","span":{"begin":16,"end":22},"obj":"JJ"},{"id":"T300","span":{"begin":12,"end":15},"obj":"CC"},{"id":"T299","span":{"begin":7,"end":11},"obj":"NN"},{"id":"T298","span":{"begin":2,"end":6},"obj":"JJ"}],"relations":[{"id":"R164","pred":"arg1Of","subj":"T299","obj":"T298"},{"id":"R165","pred":"arg1Of","subj":"T299","obj":"T300"},{"id":"R166","pred":"arg1Of","subj":"T300","obj":"T304"},{"id":"R167","pred":"arg2Of","subj":"T302","obj":"T300"},{"id":"R168","pred":"arg1Of","subj":"T302","obj":"T301"},{"id":"R169","pred":"arg1Of","subj":"T304","obj":"T303"},{"id":"R170","pred":"arg1Of","subj":"T304","obj":"T307"},{"id":"R171","pred":"arg2Of","subj":"T305","obj":"T304"},{"id":"R173","pred":"arg1Of","subj":"T307","obj":"T306"},{"id":"R174","pred":"arg2Of","subj":"T310","obj":"T307"},{"id":"R175","pred":"arg1Of","subj":"T310","obj":"T308"},{"id":"R176","pred":"arg1Of","subj":"T310","obj":"T309"},{"id":"R177","pred":"arg1Of","subj":"T310","obj":"T311"},{"id":"R178","pred":"arg2Of","subj":"T312","obj":"T311"},{"id":"R179","pred":"arg1Of","subj":"T313","obj":"T314"},{"id":"R180","pred":"arg1Of","subj":"T318","obj":"T316"},{"id":"R181","pred":"arg1Of","subj":"T318","obj":"T317"},{"id":"R182","pred":"arg1Of","subj":"T318","obj":"T319"},{"id":"R183","pred":"arg1Of","subj":"T318","obj":"T322"},{"id":"R184","pred":"arg1Of","subj":"T318","obj":"T326"},{"id":"R185","pred":"arg2Of","subj":"T318","obj":"T327"},{"id":"R186","pred":"arg2Of","subj":"T321","obj":"T319"},{"id":"R187","pred":"arg1Of","subj":"T321","obj":"T320"},{"id":"R188","pred":"arg2Of","subj":"T325","obj":"T322"},{"id":"R189","pred":"arg1Of","subj":"T325","obj":"T323"},{"id":"R190","pred":"arg1Of","subj":"T325","obj":"T324"},{"id":"R191","pred":"arg2Of","subj":"T327","obj":"T314"},{"id":"R192","pred":"arg1Of","subj":"T327","obj":"T315"},{"id":"R193","pred":"arg2Of","subj":"T327","obj":"T326"},{"id":"R194","pred":"modOf","subj":"T327","obj":"T328"},{"id":"R196","pred":"arg2Of","subj":"T331","obj":"T329"},{"id":"R197","pred":"arg1Of","subj":"T331","obj":"T330"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"t wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to overcome TMZ resistance a"}

    simple1

    {"project":"simple1","denotations":[{"id":"T165","span":{"begin":152,"end":155},"obj":"Protein"},{"id":"T164","span":{"begin":109,"end":113},"obj":"Protein"},{"id":"T163","span":{"begin":76,"end":80},"obj":"Protein"},{"id":"T162","span":{"begin":23,"end":26},"obj":"Protein"}],"text":"t wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to overcome TMZ resistance a"}